The knockdown of RNASEH1‐AS1 expression decreased the motility of the NSCLC cells, while pcDNA3.1‐RNASEH1‐AS1 treatment yielded the opposite result (Figure 3A,B). This evidence concerns the gene RNASEH1 and non-small cell lung carcinoma.